XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Sep. 30, 2022
Current assets    
Cash and equivalents $ 8,051 $ 1,804
Receivables, less allowances of $100 in 2022 and $100 in 2023 2,518 2,261
Inventories 2,006 1,742
Other current assets 1,244 1,301
Current assets held-for-sale 0 1,398
Total current assets 13,819 8,506
Property, plant and equipment, net 2,363 2,239
Other assets    
Goodwill 14,480 13,946
Other intangible assets 6,263 6,572
Copeland note receivable and equity investment 3,255 0
Other 2,566 2,151
Noncurrent assets held-for-sale 0 2,258
Total other assets 26,564 24,927
Total assets 42,746 35,672
Current liabilities    
Short-term borrowings and current maturities of long-term debt 547 2,115
Accounts payable 1,275 1,276
Accrued expenses 3,210 3,038
Current liabilities held-for-sale 0 1,348
Total current liabilities 5,032 7,777
Long-term debt 7,610 8,259
Other liabilities 3,506 3,153
Noncurrent liabilities held-for-sale 0 167
Equity    
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 591.4 shares in 2022; 572.0 shares in 2023 477 477
Additional paid-in-capital 62 57
Retained earnings 40,070 28,053
Accumulated other comprehensive income (loss) (1,253) (1,485)
Cost of common stock in treasury, 362.0 shares in 2022; 381.4 shares in 2023 (18,667) (16,738)
Common stockholders’ equity 20,689 10,364
Noncontrolling interests in subsidiaries 5,909 5,952
Total equity 26,598 16,316
Total liabilities and equity $ 42,746 $ 35,672